Bravelle (Urofollitropin)

Bravelle is called Fostimon in UK.

Introduction about Bravelle (Urofollitropin)

Bravelle (Urofollitropin) is a medication primarily used in assisted reproductive technologies to help women who are undergoing fertility treatments. It is used to stimulate the development of ovarian follicles, which are necessary for ovulation and subsequent conception.

Product Highlights

• Urofollitropin, which is a purified form of follicle-stimulating hormone (FSH) extracted from the urine of postmenopausal women.
• Fertility medication used to stimulate ovarian follicle development in women undergoing assisted reproductive technologies.
• Urofollitropin, a purified form of follicle-stimulating hormone (FSH).
• Available as a lyophilized (freeze-dried) powder that is reconstituted with a provided diluent before injection.
• Often used in combination with other fertility medications or procedures, such as IVF (in vitro fertilization) or IUI (intrauterine insemination).

Key Ingredient

• Urofollitropin

Key Benefits

• Stimulates the growth and maturation of ovarian follicles, which is essential for ovulation.
• Used in conjunction with other medications or procedures in fertility treatments such as in vitro fertilization (IVF) or intrauterine insemination (IUI).
• Allows for precise control over the dosage of FSH to optimize the chances of successful ovulation.

Direction for Use

• Bravelle is administered as an injection. The exact dosage and schedule depend on the specific fertility protocol prescribed by your healthcare provider.
• The powder must be reconstituted with the provided diluent before injection.
• Typically injected subcutaneously (under the skin) in the abdomen or thigh.

Safety Concern

• Common side effects include abdominal pain, headache, nausea, and injection site reactions. Serious side effects could include ovarian hyperstimulation syndrome (OHSS), which can cause severe abdominal pain and swelling.
• Regular monitoring by a healthcare provider is essential to check for signs of ovarian hyperstimulation and other potential issues.

Avoid Bravelle (Urofollitropin) If

• Do not use Bravelle if you are already pregnant.
• If you have ovarian cysts or enlarged ovaries not due to polycystic ovary syndrome (PCOS), Bravelle should be avoided.
• If you are allergic to urofollitropin or any of its components, you should not use this medication.
• Individuals with a history of severe liver or kidney disease, or other significant health conditions that could be exacerbated by this medication, should avoid its use.